机构:[1]State Key Laboratory of Oncology in South China, CollaborativeInnovation Center for Cancer Medicine, Guangdong Key Laboratoryof Nasopharyngeal Carcinoma Diagnosis and Therapy, Departmentof Nasopharyngeal Carcinoma, Sun Yat-Sen University CancerCenter, Guangzhou 510060, P. R. China[2]Department of Radiation Oncology, Shandong Cancer Hospitaland Institute, Shandong First Medical University and ShandongAcademy of Medical Sciences, Jinan 250117, P. R. China[3]Department of Radiation Oncology, Xiang’an Hospital of XiamenUniversity, School of Medicine, Xiamen University, Xiamen, P. R. China[4]Ningxia Key Laboratory for Cerebrocranical Disease, Ningxia MedicalUniversity, Yinchuan 750001 Ningxia, P. R. China[5]Institute of Gastroenterology, the Sixth Affiliated Hospital of Sun Yat-senUniversity, Guangzhou 510655 Guangdong, P. R. China[6]Department of Traditional Chinese Medicine, the First Affiliated Hospitalof Sun Yat-Sen University, Guangzhou 510080 Guangdong, P. R. China中山大学附属第一医院[7]Department of Medical Oncology, Sun Yat-Sen University CancerCenter, Guangzhou 510060, P. R. China[8]Department of Plastic Surgery, the First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong 510080, P. R. China中山大学附属第一医院[9]Guangzhou Concord Cancer Center, Guangzhou, P. R. China
Nasopharyngeal carcinoma (NPC) is a unique head and neck cancer with highly aggressive and metastatic potential in which distant metastasis is the main reason for treatment failure. Till present, the underlying molecular mechanisms of NPC metastasis remains poorly understood. Here, we identified S100 calcium-binding protein A14 (S100A14) as a functional regulator suppressing NPC metastasis by inhibiting the NF-kB signaling pathway and reversing the epithelial-mesenchymal transition (EMT). S100A14 was found to be downregulated in highly metastatic NPC cells and tissues. Immunohistochemical staining of 202 NPC samples revealed that lower S100A14 expression was significantly correlated with shorter patient overall survival (OS) and distant metastasis-free survival (DMFS). S100A14 was also found as an independent prognostic factor for favorable survival. Gain- and loss-of-function studies confirmed that S100A14 suppressed the in vitro and in vivo motility of NPC cells. Mechanistically, S100A14 promoted the ubiquitin-proteasome-mediated degradation of interleukin-1 receptor-associated kinase 1 (IRAK1) to suppress NPC cellular migration. Moreover, S100A14 and IRAK1 established a feedback loop that could be disrupted by the IRAK1 inhibitor T2457. Overall, our findings showed that the S100A14-IRAK1 feedback loop could be a promising therapeutic target for NPC metastasis.
第一作者机构:[1]State Key Laboratory of Oncology in South China, CollaborativeInnovation Center for Cancer Medicine, Guangdong Key Laboratoryof Nasopharyngeal Carcinoma Diagnosis and Therapy, Departmentof Nasopharyngeal Carcinoma, Sun Yat-Sen University CancerCenter, Guangzhou 510060, P. R. China[2]Department of Radiation Oncology, Shandong Cancer Hospitaland Institute, Shandong First Medical University and ShandongAcademy of Medical Sciences, Jinan 250117, P. R. China
共同第一作者:
通讯作者:
通讯机构:[1]State Key Laboratory of Oncology in South China, CollaborativeInnovation Center for Cancer Medicine, Guangdong Key Laboratoryof Nasopharyngeal Carcinoma Diagnosis and Therapy, Departmentof Nasopharyngeal Carcinoma, Sun Yat-Sen University CancerCenter, Guangzhou 510060, P. R. China[9]Guangzhou Concord Cancer Center, Guangzhou, P. R. China
推荐引用方式(GB/T 7714):
Meng Dong-Fang,Sun Rui,Liu Guo-Ying,et al.S100A14 suppresses metastasis of nasopharyngeal carcinoma by inhibition of NF-kB signaling through degradation of IRAK1.[J].ONCOGENE.2020,39(30):5307-5322.doi:10.1038/s41388-020-1363-8.
APA:
Meng Dong-Fang,Sun Rui,Liu Guo-Ying,Peng Li-Xia,Zheng Li-Sheng...&Qian Chao-Nan.(2020).S100A14 suppresses metastasis of nasopharyngeal carcinoma by inhibition of NF-kB signaling through degradation of IRAK1..ONCOGENE,39,(30)
MLA:
Meng Dong-Fang,et al."S100A14 suppresses metastasis of nasopharyngeal carcinoma by inhibition of NF-kB signaling through degradation of IRAK1.".ONCOGENE 39..30(2020):5307-5322